Atlanta, Georgia--(Newsfile Corp. - November 3, 2020) - Holzer & Holzer, LLC is investigating whether Neovasc Inc. (NASDAQ: NVCN) ("Neovasc" or the "Company") complied with federal securities laws. On October 28, 2020, the Company announced that the FDA voted on its Neovasc Reducer and found against issuing a reasonable assurance of effectiveness and against whether the benefits outweigh the relative risks. The price of Neovasc's stock fell following the announcement.
If you purchased shares of Neovasc and suffered a loss on that investment, you are encouraged to contact Marshall P. Dees, Esq. at mdees@holzerlaw.com or Luke R. Kennedy, Esq. at lkennedy@holzerlaw.com, or by toll-free telephone at (888) 508-6832 to discuss your legal rights.
Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.
CONTACT:
Corey D. Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/67395
